Who is sponsoring NCT03379766?

NCT03379766 is sponsored by Sonova AG.

What drugs are being tested in NCT03379766?

Interventions in NCT03379766: Successor of Phonak Audéo B-Direct, Phonak Audéo B-Direct.

What condition does NCT03379766 study?

NCT03379766 studies Hearing Loss, Sensorineural.

Is NCT03379766 still recruiting?

NCT03379766 is currently completed. Last updated 9 March 2018.

Last reviewed 2018-03-09 · How we verify

NCT03379766

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Quality Control of CE-Certified Phonak Hearing Aids - 2017_37

Completed NA Last updated 9 March 2018

What this trial tests

NA trial testing Successor of Phonak Audéo B-Direct in Hearing Loss, Sensorineural in 20 participants. Completed in 2 February 2018.

Timeline

8 January 2018

Primary endpoint
2 February 2018

2 February 2018

Quick facts

Lead sponsor	Sonova AG
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	single
Primary purpose	treatment
Enrollment	20
Start date	8 January 2018
Primary completion	2 February 2018
Estimated completion	2 February 2018
Sites	1 location across Switzerland

Drugs / interventions tested

Successor of Phonak Audéo B-Direct
Phonak Audéo B-Direct

Conditions studied

Hearing Loss, Sensorineural — all drugs for Hearing Loss, Sensorineural →

Sponsor

Sonova AG — full company profile →

Who can join

18 and older, any sex, with Hearing Loss, Sensorineural. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Phonak Hearing Systems pass through different development and study stages. At an early stage, feasibility studies are conducted to investigate new algorithms, features and functions in an isolated manner. If the benefit is proven, their performance is then investigated regarding interdependency between all available algorithms, features and functions running in parallel in a hearing aid (pivotal/pre-validation studies) and, as a result, they get optimized. Afterwards, and prior to product launch, the Phonak Hearing Systems undergo a final quality control in terms of clinical trials. This is a pre-validation study, investigating optimized algorithms, features and functions. This will be a clinical evaluation which will be conducted mono centric at Sonova AG Headquarters based in Stäfa (Switzerland).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Hearing Loss, Sensorineural

Currently open trials in the same condition.

NCT06499805 — Barriers and Facilitators to OTC Hearing Aids Success · NA · recruiting
NCT06560918 — Self-efficacy-based Auditory Rehabilitation With Over-the-Counter Hearing Aids · NA · recruiting
NCT06882889 — Comparing the Efficacy of Domestic Versus Imported Hearing Aids in ARHL · NA · recruiting
NCT06664697 — Post-Market Clinical Investigation of the IotaSOFT Insertion System · recruiting
NCT06268340 — Hearing and Structure Preservation Via ECochG · NA · recruiting

Other Sonova AG trials

Trials by the same sponsor.

NCT07526428 — Investigating the DNN Noise Reduction Feature in Phonak Hearing Aids Using Ecological Momentary Assessment · NA · enrolling by invitation
NCT07501312 — Remote Microphone Performance Comparison in Adults With Hearing Loss · NA · enrolling by invitation
NCT07414329 — Efficacy and Effectiveness of an Investigational Behind-the-Ear Hearing Device Kit · NA · recruiting
NCT06957730 — A Comparison of Hearing Aid Noise Programs on Speech Intelligibility · NA · completed
NCT06746038 — Evaluation of Extended Wear Hearing Aid for Mild Hearing Loss · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03379766 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Sonova AG
Last refreshed: 9 March 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03379766.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing